{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:17:43Z","timestamp":1761898663525,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RU 1936\/1-2"],"award-info":[{"award-number":["RU 1936\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clinre.2021.101791","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T23:32:47Z","timestamp":1628897567000},"page":"101791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Possible role of the HMGB1 and RAGE inflammatory pathway in primary sclerosing cholangitis"],"prefix":"10.1016","volume":"46","author":[{"given":"Sander","family":"Julia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sauer","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiss","family":"Karl-Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gotthardt","family":"Daniel Nils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-9230","authenticated-orcid":false,"given":"Rupp","family":"Christian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinre.2021.101791_bib0001","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2021.101791_bib0002","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.clinre.2021.101791_bib0004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.clinre.2021.101791_bib0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2021.101791_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.clinre.2021.101791_bib0007","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/apt.12663","article-title":"Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis","volume":"39","author":"Rupp","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clinre.2021.101791_bib0008","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/gutjnl-2017-314249","article-title":"Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?","volume":"66","author":"O'Hara","year":"2017","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.clinre.2021.101791_bib0009","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.13154","article-title":"A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease","volume":"41","author":"Eaton","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinre.2021.101791_bib0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MPG.0000000000000995","article-title":"Environmental risk factors of pediatriconset primary sclerosing cholangitis and autoimmune hepatitis","volume":"62","author":"Tenca","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0011","doi-asserted-by":"crossref","first-page":"e29821","DOI":"10.1371\/journal.pone.0029821","article-title":"S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis","volume":"7","author":"Reinhard","year":"2012","journal-title":"PLoS One"},{"issue":"28","key":"10.1016\/j.clinre.2021.101791_bib0012","doi-asserted-by":"crossref","first-page":"17810","DOI":"10.1074\/jbc.272.28.17810","article-title":"Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress","volume":"272","author":"Lander","year":"1997","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.clinre.2021.101791_bib0013","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2337\/diabetes.50.6.1495","article-title":"Requirement for p38 and p44\/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion","volume":"50","author":"Yeh","year":"2001","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.clinre.2021.101791_bib0014","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1084\/jem.20120201","article-title":"RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA","volume":"210","author":"Sirois","year":"2013","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.clinre.2021.101791_bib0015","first-page":"445","article-title":"Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer","volume":"10","author":"Kuniyasu","year":"2003","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.clinre.2021.101791_bib0016","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/onc.2012.631","article-title":"The HMGB1\/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics","volume":"33","author":"Kang","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.clinre.2021.101791_bib0017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1515\/revneuro-2015-0003","article-title":"Receptor for advanced glycation end-products in neurodegenerative diseases","volume":"26","author":"Juranek","year":"2015","journal-title":"Rev Neurosci"},{"issue":"4","key":"10.1016\/j.clinre.2021.101791_bib0018","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","article-title":"RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy","volume":"162","author":"Wendt","year":"2003","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.clinre.2021.101791_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2005.032391","article-title":"Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease","volume":"60","author":"Butscheid","year":"2007","journal-title":"J Clin Pathol"},{"issue":"43","key":"10.1016\/j.clinre.2021.101791_bib0021","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.clinre.2021.101791_bib0022","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.clinre.2021.101791_bib0023","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/MCB.18.8.4471","article-title":"High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells","volume":"18","author":"Boonyaratanakornkit","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"24","key":"10.1016\/j.clinre.2021.101791_bib0024","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1093\/emboj\/cdf692","article-title":"The DNA chaperone HMGB1 facilitates ACF\/CHRAC-dependent nucleosome sliding","volume":"21","author":"Bonaldi","year":"2002","journal-title":"EMBO J"},{"issue":"6894","key":"10.1016\/j.clinre.2021.101791_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"5425","key":"10.1016\/j.clinre.2021.101791_bib0026","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.clinre.2021.101791_bib0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"issue":"26","key":"10.1016\/j.clinre.2021.101791_bib0028","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.clinre.2021.101791_bib0029","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.4049\/jimmunol.180.7.5067","article-title":"High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes","volume":"180","author":"Youn","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.clinre.2021.101791_bib0030","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3892\/etm.2014.1904","article-title":"High mobility group box 1 release from cholangiocytes in patients with acute-on-chronic liver failure","volume":"8","author":"Xu","year":"2014","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.clinre.2021.101791_bib0031","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/lt.24129","article-title":"Acute liver failure study G. circulating levels of soluble rage and rage-ligands in patients with acute liver failure","volume":"21","author":"Basta","year":"2015","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"issue":"9","key":"10.1016\/j.clinre.2021.101791_bib0032","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.bbadis.2014.06.017","article-title":"Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis","volume":"1842","author":"Kao","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<1::AID-IJC1>3.0.CO;2-6","article-title":"Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa","volume":"74","author":"Xiang","year":"1997","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clinre.2021.101791_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000218331","article-title":"Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer","volume":"76","author":"Kusume","year":"2009","journal-title":"Pathobiology"},{"key":"10.1016\/j.clinre.2021.101791_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/946748","article-title":"HMGB1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response","volume":"2015","author":"Lu","year":"2015","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SHK.0b013e3181997173","article-title":"HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans","volume":"32","author":"Peltz","year":"2009","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.clinre.2021.101791_bib0037","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","article-title":"Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock","volume":"33","author":"Sunden-Cullberg","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1189\/jlb.0306196","article-title":"Factors masking HMGB1 in human serum and plasma","volume":"81","author":"Urbonaviciute","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.clinre.2021.101791_bib0039","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.clinre.2021.101791_bib0040","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1007\/s10620-015-3805-7","article-title":"Individuals with primary sclerosing cholangitis have elevated levels of biomarkers for apoptosis but not necrosis","volume":"60","author":"Masuoka","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.clinre.2021.101791_bib0041","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","article-title":"Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein","volume":"29","author":"Kazama","year":"2008","journal-title":"Immunity"},{"issue":"11-12","key":"10.1016\/j.clinre.2021.101791_bib0042","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/apt.12979","article-title":"Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis","volume":"40","author":"Rupp","year":"2014","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:37Z","timestamp":1761895897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740121001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2210740121001704"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101791","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible role of the HMGB1 and RAGE inflammatory pathway in primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101791"}}